http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018175323-A4

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_097a9f5e134fc70113c240fe6e139b8c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e5a35f1bccac8690e3fe5caf89045030
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-141
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2320-31
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-113
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6455
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-645
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-554
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-1137
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-1136
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-1138
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6929
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-713
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-113
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-575
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-641
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7105
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7068
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7068
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-113
filingDate 2018-03-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7a2e4c77d14f55da576c3abdacdec354
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d18269f4514f9abaaabf2f3ccf0aee2b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e82729218a79e0e24259f5c60aa54e23
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f1878fd8d2d410f1269101a4eb301e8b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2226b9eb52b944759afc2930d6cb983d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3d38a83c33ee4cffe65e4997fc810f63
publicationDate 2018-11-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2018175323-A4
titleOfInvention Gemcitabine derivatives for cancer therapy
abstract The present invention provides pharmaceutical compositions comprising the chemotherapy drug gemcitabine (GEM) and certain derivatives, a taurocholic acid (TCA) formulation, and a Histidine-Lysine Polymer (HKP) conjugate, for enhancement of RNAi cancer therapeutics.
priorityDate 2017-03-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3461
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414856754
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6675
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13020211
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419477666
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395830
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1123
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395831
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID46936954
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419482441
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23666345
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396322
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60750
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID222528
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449868975
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535249
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419489743

Total number of triples: 53.